13M152: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders I: Imaging (1645–1650)

Presenting Author(s)

• DB

  Daniel Blockmans, MD

  University Hospital Gasthuisberg
  Leuven, Belgium

  Disclosure information not submitted.
• KP

  Keren Port, MBBS

  The Prince of Wales Hospital
  Woollahra, New South Wales, Australia

  Disclosure information not submitted.
• CR

  Carolyn Ross, MD

  University of Montreal
  Montréal, QC, Canada

  Disclosure information not submitted.
• AS

  Anthony Sammel, PhD, MBBS

  Prince of Wales Hospital
  Sydney, New South Wales, Australia

  Disclosure information not submitted.
• 

  Valentin Sebastian Schäfer, MD

  University Hospital Bonn
  53127 Bonn, Germany

  Disclosure information not submitted.
• 

  Wolfgang Schmidt, MD, MACR

  Immanuel Krankenhaus Berlin
  Berlin, Germany

  Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Chugai: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKline(GSK): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medac: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Roche: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Abstract oral session.

Non-CME

Presentations:

• 2:00 PM - 2:10 PM PT

  Aortic Dilatation and PET/CT Vascular Activity at Diagnosis and 5 Years in an Inception Giant Cell Arteritis (GCA) Cohort
  

  Presenting Author: Anthony Sammel, PhD, MBBS – Prince of Wales Hospital
• 2:10 PM - 2:15 PM PT

  Q&A
  
• 2:15 PM - 2:25 PM PT

  The Real-World Experience of Combined Cranial and Large Vessel FDG-PET/CT in the Investigation of Giant Cell Arteritis
  

  Presenting Author: Keren Port, MBBS – The Prince of Wales Hospital
• 2:25 PM - 2:30 PM PT

  Q&A
  
• 2:30 PM - 2:40 PM PT

  Association Between Vascular FDG Uptake at Diagnosis and Evolution in Aortic Dimensions in Giant Cell Arteritis: A Prospective Study
  

  Presenting Author: Daniel Blockmans, MD – University Hospital Gasthuisberg
• 2:40 PM - 2:45 PM PT

  Q&A
  
• 2:45 PM - 2:55 PM PT

  EULAR Recommendations for the Use of Imaging in Large Vessel Vasculitis in Clinical Practice: 2023 Update
  

  Presenting Author: Wolfgang Schmidt, MD, MACR – Immanuel Krankenhaus Berlin
• 2:55 PM - 3:00 PM PT

  Q&A
  
• 3:00 PM - 3:10 PM PT

  Follow-up Ultrasound Examination in Patients with Newly Diagnosed Giant Cell Arteritis
  

  Presenting Author: Valentin Sebastian Schäfer, MD – University Hospital Bonn
• 3:10 PM - 3:15 PM PT

  Q&A
  
• 3:15 PM - 3:25 PM PT

  Optic Nerve Sheath Measurement as a Disease Activity Biomarker in Giant Cell Arteritis
  

  Presenting Author: Carolyn Ross, MD – University of Montreal
• 3:25 PM - 3:30 PM PT

  Q&A